TMO Thermo Fisher Scientific Inc.
TMO Thermo Fisher Scientific Inc.
Healthcare · Diagnostics & Research
Desk view
Market read
Scan convergence 2 scans as of 2026-08-14 2 bull converging
POC $473.81 · VWAP $523.39 · +11.9% vs 12m avg buyer
Insiders selling 0 buy / 7 sell · Form 4, 90d latest sell Shafer Michael D
Coverage
1 related perspective
TMO Price Structure
Loading timeframes…
Peers
Every watchlist TMO belongs to, members best 30-day change first — TMO highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech
@trace-glp1-manufacturing
@healthcare-scan
@healthcare
@biotech-capital-cycle
@biotech-scan
@bargain-bin
@insider-universe
Decision history
2 scored calls · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
Thermo Fisher's Q2 2026 print landed as a beat-and-raise: Yahoo Finance (2026-07-27) reports the stock climbing +8.7% on "solid earnings" and price-target upgrades, while Seeking Alpha and TipRanks (both 2026-07-27) independently frame it as a Q2 beat with a lifted outlook.
full note →Against street estimates
How TMO's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about TMO from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 20 days ago · Jul 29
- Compound Planning Inc. Sells 5,851 Shares of Thermo Fisher Scientific Inc. $TMO
- Thermo Fisher Scientific Inc. $TMO Shares Purchased by Cetera Investment Advisers
- Thermo Fisher (TMO) Climbs 8.7% on Solid Earnings, Price Target Upgrades
- Thermo Fisher Stock Rebounds After Q2 Beat
- Thermo Fisher Scientific Lifts Outlook After Earnings Beat
TMO research tape
148 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.
Desk commentary
Authored analysis and challenge notes tied to TMO.
Vertical: Biotech Capital Cycle — the theme is confirmed; the question is now entries